載入...
Clinical exacerbation of SARS‐CoV2 infection after fingolimod withdrawal
The role of disease‐modifying therapies in patients with autoimmune disorders during severe acute respiratory syndrome coronavirus 2 (SARS‐CoV2) infection is controversial. Immunocompromised patients could have a more severe coronavirus disease‐2019 (COVID‐19) due to the absence of an adequate immun...
Na minha lista:
| 發表在: | J Med Virol |
|---|---|
| Main Authors: | , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
John Wiley and Sons Inc.
2020
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7361541/ https://ncbi.nlm.nih.gov/pubmed/32644205 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jmv.26279 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|